天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Methyl 3-Chloro-4-piperazinobenzoate

Methyl 3-Chloro-4-piperazinobenzoate Struktur
234082-16-7
CAS-Nr.
234082-16-7
Englisch Name:
Methyl 3-Chloro-4-piperazinobenzoate
Synonyma:
Methyl 3-Chloro-4-piperazinobenzoate;methyl 3-chloro-4-(piperazin-1-yl)benzoate;Benzoic acid, 3-chloro-4-(1-piperazinyl)-, methyl ester
CBNumber:
CB12597189
Summenformel:
C12H15ClN2O2
Molgewicht:
254.71
MOL-Datei:
234082-16-7.mol

Methyl 3-Chloro-4-piperazinobenzoate Eigenschaften

Sicherheit

HS Code  2933599590

Methyl 3-Chloro-4-piperazinobenzoate Chemische Eigenschaften,Einsatz,Produktion Methoden

Methyl 3-Chloro-4-piperazinobenzoate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Methyl 3-Chloro-4-piperazinobenzoate Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 19)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Accela ChemBio Inc.
+1-858-6993322
info@accelachem.com United States 17777 58
Alchem Pharmtech,Inc.
8485655694
sales@alchempharmtech.com United States 63687 58
Fuxin Pharmaceutical
+86-021-021-50872116 +8613122107989
contact@fuxinpharm.com China 10032 58
Amadis Chemical Company Limited
571-89925085
sales@amadischem.com China 131957 58
Shanghai civi chemical technology co.,Ltd 86-21-34053660
sale@labgogo.com China 9865 52
ShangHai AmK Pharmaceutical Technology Co., Ltd. 18019252918
sale@amkchem.com China 15297 55
Shanghai Jizhi Biochemical Technology Co. Ltd. 4009004166/18616739031 18616739031
3007523370@qq.com China 52693 58
Accela ChemBio Co.,Ltd. 021-50795510 4000665055
sales@accelachem.com China 11725 58
Jiangsu yize medical technology co. LTD 18962082606
3394205705@qq.com China 9836 58
Beijing Haite lesk Technology Co., Ltd 15210893940; 15116916250
chemistryliu@163.com China 7327 58

  • Methyl 3-Chloro-4-piperazinobenzoate
  • methyl 3-chloro-4-(piperazin-1-yl)benzoate
  • Benzoic acid, 3-chloro-4-(1-piperazinyl)-, methyl ester
  • 234082-16-7
Copyright 2019 ? ChemicalBook. All rights reserved